Search Results

• • 274 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics.

  Authors:Lawrence Corey, Russell Corbett-Detig, and Chris BeyrerFrom:JAMA, The Journal of the American Medical Association (Vol. 327, Issue 13) Peer-Reviewed

  Apr. 5, 202241 words Viewpoint essay

   Citation Only

• Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.

  Authors:Jerald Sadoff, Glenda Gray, An Vandebosch, Vicky Cardenas, Georgi Shukarev, Beatriz Grinsztejn, et al.From:The New England Journal of Medicine (Vol. 386, Issue 9) Peer-Reviewed

  Mar. 3, 202256 words Report

   Citation Only

• Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.

  Authors:Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott, Youyi Fong, David Benkeser, Weiping Deng, et al.From:Science (Vol. 375, Issue 6576) Peer-Reviewed

  Jan. 7, 20226,872 words Article 1750L

   Abstract Only

• Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.

  Authors:Ann R. Falsey, Magdalena E. Sobieszcyk, Ian Hirsch, Stephanie Sproule, Merlin L. Robb, Lawrence Corey, et al.From:The New England Journal of Medicine (Vol. 385, Issue 25) Peer-Reviewed

  Dec. 16, 202133 words Report

   Citation Only

• Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.

  Authors:Hana M. el- Sahly, Lindsey R. Baden, Brandon Essink, Susanne Doblecki-Lewis, Judith M. Martin, Evan J. Anderson, et al.From:The New England Journal of Medicine (Vol. 385, Issue 19) Peer-Reviewed

  Nov. 4, 202159 words Report

   Citation Only

• Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)

  Authors:Ann Duerr, Yunda Huang, Susan Buchbinder, Robert W. Coombs, Jorge Sanchez, Carlos del Rio, et al.From:Journal of Infectious Diseases (Vol. 206, Issue 2) Peer-Reviewed

  July 15, 2012 Report

   Citation Only

• Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial

  Authors:Karen E. Mark, Lawrence Corey, Tze-Chiang Meng, Amalia S. Magaret, Meei-Li Huang, Stacy Selke, et al.From:Journal of Infectious Diseases (Vol. 195, Issue 9) Peer-Reviewed

  May 1, 2007 Article

   Citation Only

• Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant

  Authors:Zane A. Brown, Anna Wald, R. Ashley Morrow, Stacy Selke, Judith Zeh, and Lawrence CoreyFrom:JAMA, The Journal of the American Medical Association (Vol. 289, Issue 2) Peer-Reviewed

  Jan. 8, 200352 words Article

   Citation Only

• Cervical shedding of herpes simplex virus and cytomegalovirus throughout the menstrual cycle in women infected with human immunodeficiency virus type 1

  Authors:Sara B. Mostad, Joan K. Kreiss, Alexander Ryncarz, Bhavna Chohan, Kishorchandra Mandaliya, Jeckoniah Ndinya-Achola, et al.From:American Journal of Obstetrics and Gynecology (Vol. 183, Issue 4) Peer-Reviewed

  Oct. 200042 words Article

   Abstract Only

• Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160

  Authors:Donald E. Mosier, Richard J. Gulizia, Paul D. MacIsaac, Lawrence Corey, and Philip D. GreenbergFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 90, Issue 6) Peer-Reviewed

  Mar. 15, 199369 words Article

   Abstract Only

• Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1

  Authors:Jane Hitti, D. Heather Watts, Sandra K. Burchett, Tim Schacker, Stacy Selke, Zane A. Brown, et al.From:American Journal of Obstetrics and Gynecology (Vol. 177, Issue 2) Peer-Reviewed

  Aug. 199785 words Article

   Abstract Only

• Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2

  Authors:Rhoda Ashley, Anne Cent, Vanna Maggs, Andre Nahmias, and Lawrence CoreyFrom:Annals of Internal Medicine (Vol. 115, Issue 7) Peer-Reviewed

  Oct. 1, 1991257 words Article

   Abstract Only

• Herpes simplex virus viremia during primary genital infection

  Authors:Christine Johnston, Amalia Magaret, Stacy Selke, Michael Remington, Lawrence Corey, and Anna WaldFrom:Journal of Infectious Diseases (Vol. 198, Issue 1) Peer-Reviewed

  July 1, 2008 Report

   Citation Only

• MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load

  Authors:Holly Janes, Nicole Frahm, Allan DeCamp, Morgane Rolland, Erin Gabriel, Julian Wolfson, et al.From:PLoS ONE (Vol. 7, Issue 8) Peer-Reviewed

  Aug. 27, 20125,830 words Article 1390LAuthor(s): Holly Janes 1 , 2 , * , Nicole Frahm 1 , 3 , Allan DeCamp 1 , Morgane Rolland 4 , Erin Gabriel 2 , Julian Wolfson 5 , Tomer Hertz 1 , Esper Kallas 6 , Paul Goepfert 7 , David P. Friedrich 1 , Lawrence Corey 1...

• Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection: Two Randomized Controlled Trials

  Authors:Lawrence Corey, Andria G. M. Langenberg, Rhoda Ashley, Rose E. Sekulovich, Allen E. Izu, John M. Douglas, et al.From:JAMA, The Journal of the American Medical Association (Vol. 282, Issue 4) Peer-Reviewed

  July 28, 199986 words Article

   Abstract Only

• Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease

  Authors:Veronique Erard, Meei-Li Huang, James Ferrenberg, Long Nguy, Terry L. Stevens-Ayers, Robert C. Hackman, et al.From:Clinical Infectious Diseases (Vol. 45, Issue 8) Peer-Reviewed

  Oct. 15, 2007 Clinical report

   Citation Only

• Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract

  Authors:Rachna Gupta, Anna Wald, Elizabeth Krantz, Stacy Selke, Terri Warren, Mauricio Vargas-Cortes, et al.From:Journal of Infectious Diseases (Vol. 190, Issue 8) Peer-Reviewed

  Oct. 15, 2004 Article

   Citation Only

• Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Tpe 1 Vaccine with or without gpl2O: A Phase 2 Study in Higher- and Lower-Risk Volunteers

  Authors:Robert B. Belshe, Cladd Stevens, Geoffrey J. Gorse, Susan Buchbinder, Kent Weinhold, Haynes Sheppard, et al.From:Journal of Infectious Diseases (Vol. 183, Issue 9) Peer-Reviewed

  May 1, 2001 Article

   Citation Only

• Viral hepatitis among young men who have sex with men: prevalence of infection, risk behaviors, and vaccination

  Authors:Catherine Diamond, Hanne Thiede, Thomas Perdue, Gina M. Secura, Linda Valleroy, Duncan MacKellar, et al.From:Sexually Transmitted Diseases (Vol. 30, Issue 5) Peer-Reviewed

  May 2003198 words Author abstract

   Abstract Only

• Preventing acquisition of HIV is the only path to an AIDS-free generation

  Authors:Lawrence Corey and Glenda E. GrayFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 114, Issue 15) Peer-Reviewed

  Apr. 11, 20172,788 words Essay 1700L

   Citation Only